Guided Therapeutics (GTHP) Change in Accured Expenses (2016 - 2025)

Guided Therapeutics (GTHP) has disclosed Change in Accured Expenses for 15 consecutive years, with $832000.0 as the latest value for Q4 2025.

  • Quarterly Change in Accured Expenses rose 433.33% to $832000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $1.4 million through Dec 2025, up 150.09% year-over-year, with the annual reading at $1.4 million for FY2025, 150.09% up from the prior year.
  • Change in Accured Expenses hit $832000.0 in Q4 2025 for Guided Therapeutics, up from $204000.0 in the prior quarter.
  • In the past five years, Change in Accured Expenses ranged from a high of $832000.0 in Q4 2025 to a low of -$450000.0 in Q3 2021.
  • Historically, Change in Accured Expenses has averaged $110450.0 across 5 years, with a median of $75000.0 in 2022.
  • Biggest five-year swings in Change in Accured Expenses: tumbled 454.33% in 2021 and later surged 2009.52% in 2024.
  • Year by year, Change in Accured Expenses stood at $571000.0 in 2021, then crashed by 77.41% to $129000.0 in 2022, then surged by 34.11% to $173000.0 in 2023, then dropped by 9.83% to $156000.0 in 2024, then soared by 433.33% to $832000.0 in 2025.
  • Business Quant data shows Change in Accured Expenses for GTHP at $832000.0 in Q4 2025, $204000.0 in Q3 2025, and $221000.0 in Q2 2025.